Please give an overview of the trial protocol?
The DAPT Study will assess the safety and effectiveness of 12 versus 30 months of dual antiplatelet therapy for preventing stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) in subjects undergoing percutaneous coronary intervention (PCI) with drug-eluting stent placement for the treatment of coronary artery lesions. The trial will be a four-year, prospective, randomized, double-blind trial that is expected to enroll over 15,000 subjects being treated with a drug-eluting stent (DES) at over 200 sites in the U.S., E.U., Australia and New Zealand. A cohort of approximately 5,000 subjects treated with a bare metal stent (BMS) will also be enrolled.
Related Questions
- I am an investigator developing a protocol for a gene transfer clinical trial. What are the first things I need to do to prepare for a review of my trial by the RAC?
- I see "OVERVIEW" but do not seem to be able to see and download the PDF version of the FIX Protocol specification documents. Why?
- Is there potential overlap in what might be considered for a clinical management trial protocol and a proof of concept study?
